ACELRX PHARMACEUTICALS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2017–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	3	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	21

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	20
SENATE	17
Health & Human Services, Dept of (HHS)	7
Executive Office of the President (EOP)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	21
Defense	Defense	12

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 1519115th Congress

National Defense Authorization Act for Fiscal Year 2018

Cited source text and reported amounts

S.1519 - National Defense Authorization Act for Fiscal Year 2018

Client expense: — · Firm income: $45,000

Matched citations: S.1519

ACELRX PHARMACEUTICALS, INC. — Lobbying Disclosure | Poliscope